Cell line · CVCL_1846
PaTu 8988s
Cancer cell line, Homo sapiens. Pancreatic adenocarcinoma. 32 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. PaTu 8988s. Cell lines, record CVCL_1846. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1846
On this page
Cell line
As Cellosaurus gives it.
- Name
- PaTu 8988s
- Accession
- CVCL_1846
- RRID
- RRID:CVCL_1846
- Synonyms
- PA-TU-8988S, PaTu8988s, PaTu8988S, PATU8988S, PaTu 8988 S, PaTu-8988s, PATU-8988S, PATU-S, PA-TU S
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 64Y
- Category
- Cancer cell line
- Diseases
- Pancreatic adenocarcinoma (NCIt C8294)
- Derived from
- Liver (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Caution | TP53 mutation indicated incorrectly as being at p.Cys176Ser (c.451C>T) in PubMed=8194712. |
Source Cellosaurus
Papers32
2 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal Adenocarcinoma. | MedComm (2020) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| GLIS3 marks a neural-like progenitor cell state that drives metastasis in pancreatic ductal adenocarcinoma. | Cell Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Inhibiting Fatty Acid Oxidation Reverses Autophagy-Mediated Acquired Chemotherapy Resistance in Pancreatic Ductal Adenocarcinoma. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| KLF5 enables dichotomous lineage programs in pancreatic cancer via the AAA+ ATPase coactivators RUVBL1 and RUVBL2. | Nat Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Integrated spatial morpho-transcriptomics predicts functional traits in pancreatic cancer. | Sci Adv | 2025 | Its Methods give the RRID and name the line | PubMed | |
| An affinity-modulated T cell engager targeting Claudin 18.2 shows potent anti-tumor activity with limited cytokine release. | J Immunother Cancer | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Label-free single-cell phenotyping to determine tumor cell heterogeneity in pancreatic cancer in real time. | JCI Insight | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Tumor microenvironment acidosis favors pancreatic cancer stem cell properties and in vivo metastasis. | iScience | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Minimally invasive determination of pancreatic ductal adenocarcinoma (PDAC) subtype by means of circulating cell-free RNA. | Mol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancers. | Clin Cancer Res | 2024 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 32
See all 32 papersRelatives1
| Relation | Cell line | Accession | Problem |
|---|---|---|---|
| From the same person | PaTu 8988t | CVCL_1847 |
Source Cell lines
Cell banks1
| Cell bank | Catalog number | Status |
|---|---|---|
| DSMZ | ACC-204 |
Source DSMZ
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1846
GET https://conductscience.org/api/cell-lines/v1/CVCL_1846/papers?page=2